Newsroom
Latest News from UNC Lineberger
-
Pancreatic Cancer SPORE Career Enhancement Awards: Highlights from the First Two YearsThe SToP Cancer SPORE grant’s Career Enhancement Program supports a diverse group of young researchers seeking to gain key insight into critical areas of pancreatic cancer research. Here are highlights … Read more
-
UNC Lineberger expands access to cancer clinical trials across North CarolinaUNC Lineberger’s J. Kaitlin Morrison, PhD, and Carrie Lee, MD, PhD, launched a study to investigate whether UNC Health can successfully conduct hybrid cancer clinical trials across the state.
-
Stein discusses latest advances in sarcoma treatment, researchJuly is Sarcoma Awareness Month. Jake Stein, MD, MPH, shares that recent advances in targeted therapies, immunotherapy and radiation techniques are improving outcomes for patients diagnosed with this group of … Read more
-
UNC honors three cancer center members with 2025 Hettleman PrizesSarah Cohen, PhD, Marissa Hall, PhD, and Lindsey James, PhD, were awarded Hettleman Prizes, which recognizes UNC-Chapel Hill early-career faculty who exemplify groundbreaking and innovative research.
-
On-demand yoga library available for patients and caregiversUNC Lineberger’s Comprehensive Cancer Support Program offers online yoga and meditation resources for cancer patients, caregivers and survivors.
-
Carey named a ‘Giant’ of breast cancer careLisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.
-
Marks to receive the American Society for Therapeutic Radiology and Oncology’s highest honorASTRO will present its Gold Medal award to UNC Lineberger’s Lawrence B. Marks, MD, FASTRO, at its annual meeting.
-
Uniquely engineered KRAS-targeted cancer drug found to be effective in early studiesChad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.
-
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancerUNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in … Read more
-
Cancer center honors graduate and postdoc award winnersUNC Lineberger celebrated emerging scientists and clinicians at its annual training awards ceremony, recognizing outstanding graduate students and postdoctoral fellows poised to advance cancer research and patient care.